Location History:
- Kamakura, JP (2012 - 2019)
- Kanagawa, JP (2021 - 2023)
Company Filing History:
Years Active: 2012-2023
Title: Yasuhiro Morita: Innovator in Pharmaceutical Crystals
Introduction
Yasuhiro Morita is a prominent inventor based in Kamakura, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline compounds that exhibit therapeutic properties. With a total of eight patents to his name, Morita's work is recognized for its potential impact on pain management and treatment.
Latest Patents
Morita's latest patents include innovative crystals of cyclic amine derivatives, which have pharmaceutical applications. One notable patent describes a crystal of ethane disulfonate of (S)-1-(4-(dimethylamino)piperidin-1-yl)-3-hydroxy-3-(1-methyl-1H-imidazol-2-yl)propan-1-one. This crystal demonstrates specific diffraction peaks at angles of 12.6±0.2, 16.0±0.2, 17.7±0.2, 18.5±0.2, and 21.3±0.2 in powder X-ray diffraction. Additionally, it has an endothermic peak observed at 173°C to 177°C during simultaneous thermogravimetric-differential thermal analysis. Another patent focuses on crystals of a compound that exhibits analgesic action against neuropathic pain and fibromyalgia syndrome, highlighting their utility as pharmaceuticals.
Career Highlights
Yasuhiro Morita is currently associated with Toray Industries, Inc., where he continues to advance his research in pharmaceutical innovations. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
Morita has collaborated with notable colleagues, including Katsuhiko Iseki and Naoki Izumimoto. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Yasuhiro Morita stands out as an influential inventor in the pharmaceutical industry, with a focus on crystalline compounds that offer significant therapeutic benefits. His contributions are paving the way for advancements in pain management and treatment options.